# Study of NMDA Antagonists and Neuropathic Pain

> **NCT01602185** · PHASE2 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 7 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Dextromethorphan (drug used like antitussive)
- **DRUG:** Memantine (drug used in Alzheimer's disease)
- **DRUG:** Placebo (lactose)

## Key facts

- **NCT ID:** NCT01602185
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-06
- **Final completion:** 2016-09-07
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602185, "Study of NMDA Antagonists and Neuropathic Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01602185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*